← All filing news

EW Healthcare Partners funds disclose 17.23% stake in Tela Bio

EW Healthcare Partners Fund 2-GP, L.P. and EW Healthcare Partners Fund 2-UGP, LLC disclosed aggregate ownership of 7,714,709 shares, or 17.23% of Tela Bio's outstanding common stock, according to a Schedule 13D filing. The reporting persons, which collectively own 17.23% through multiple fund entities, stated that an operating partner affiliated with them was appointed to the board on June 9, 2026. The filers stated they have no present plan or proposal relating to any other events specified in Schedule 13D Item 4.

Key facts

  • EW Healthcare Partners Fund 2-GP, L.P. owns 7,714,709 shares, 17.23% of class
  • EW Healthcare Partners Fund 2-UGP, LLC owns 7,714,709 shares, 17.23% of class
  • EW Healthcare Partners Fund 2, L.P. owns 3,031,617 shares, 6.77% of class
  • EW Healthcare Partners Fund 2-A, L.P. owns 4,683,092 shares, 10.46% of class
  • Operating partner appointed to board on June 9, 2026
  • All reporting persons are Delaware limited partnerships or limited liability companies

Why it matters

The aggregate stake of approximately 17.23% makes EW Healthcare Partners a significant shareholder in Tela Bio with board representation, which may influence strategic direction and governance.

Share

Track EW HEALTHCARE PARTNERS FUND 2, L.P. →

Get the next chapter in your inbox — a Sentinel watches this company and briefs the next material filing the moment it lands.

Derived from SCHEDULE 13D filed 2026-06-09. Not investment advice. View the source filing on SEC.gov →